FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysis

References

• Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, Spaulding MB. (1998). Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206:755–760.
   PubMed Web of Science ®Google Scholar
• Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H. (2003). FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 28:192–197.
   PubMed Web of Science ®Google Scholar
• Antoch G, Vogt FM, Veit P, Freudenberg LS, Blechschmid N, Dirsch O, Bockisch A, Forsting M, Debatin JF, Kuehl H. (2005). Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med 46:520–525.
   PubMed Web of Science ®Google Scholar
• Ayav A, Germain A, Marchal F, Tierris I, Laurent V, Bazin C, Yuan Y, Robert L, Brunaud L, Bresler L. (2010). Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200:435–439.
   PubMed Web of Science ®Google Scholar
• Battaglia M, Bucher H, Egger M, Grossenbacher F, Minder C, Pewsner D. (2002). The Bayes library of diagnostic studies and reviews, 2nd edition, Basel, Switzerland: University of Basel.
   Google Scholar
• Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, Stoker J. (2005). Colorectal liver metastases: CT, MR imaging, and PET for diagnosis–meta-analysis. Radiology 237:123–131.
   PubMed Web of Science ®Google Scholar
• Blokhuis TJ, van der Schaaf MC, van den Tol MP, Comans EF, Manoliu RA, van der Sijp JR. (2004). Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning. Scand J Gastroenterol Suppl: 93–97.
   PubMedGoogle Scholar
• Curley SA. (2001). Radiofrequency ablation of malignant liver tumors. Oncologist 6:14–23.
   PubMed Web of Science ®Google Scholar
• Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright JK Jr, Chapman WC, Pinson CW. (1997). Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196–1201.
   PubMed Web of Science ®Google Scholar
• Donckier V, Van Laethem JL, Goldman S, Van Gansbeke D, Feron P, Ickx B, Wikler D, Gelin M. (2003). [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 84:215–223.
   PubMed Web of Science ®Google Scholar
• Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V, Petrow P, Roche A, Sigal R. (2002). Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223:255–262.
   PubMed Web of Science ®Google Scholar
• Eisele RM, Neumann U, Neuhaus P, Schumacher G. (2009). Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases. World J Surg 33:804–811.
   PubMed Web of Science ®Google Scholar
• Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC, Mosteller F. (1994). Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120:667–676.
   PubMed Web of Science ®Google Scholar
• Irwig L, Macaskill P, Glasziou P, Fahey M. (1995). Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol 48:119–30; discussion 131.
   PubMed Web of Science ®Google Scholar
• Khandani AH, Calvo BF, O’Neil BH, Jorgenson J, Mauro MA. (2007). A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases. AJR Am J Roentgenol 189:1199–1202.
   PubMed Web of Science ®Google Scholar
• Kuehl H, Antoch G, Stergar H, Veit-Haibach P, Rosenbaum-Krumme S, Vogt F, Frilling A, Barkhausen J, Bockisch A. (2008). Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results. Eur J Radiol 67:362–371.
   PubMed Web of Science ®Google Scholar
• Kuvshinoff BW, Ota DM. (2002). Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 132:605–11; discussion 611.
   PubMed Web of Science ®Google Scholar
• Langenhoff BS, Oyen WJ, Jager GJ, Strijk SP, Wobbes T, Corstens FH, Ruers TJ. (2002). Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 20:4453–4458.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Cioni D, Bartolozzi C. (2001). Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 26:345–360.
   PubMedGoogle Scholar
• Lim HK, Choi D, Lee WJ, Kim SH, Lee SJ, Jang HJ, Lee JH, Lim JH, Choo IW. (2001). Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221:447–454.
   PubMed Web of Science ®Google Scholar
• Liu ZY, Chang ZH, Lu ZM, Guo QY. (2010). Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful? Chin Med J 123:1690–1694.
   PubMed Web of Science ®Google Scholar
• Lubezky N, Metser U, Geva R, Nakache R, Shmueli E, Klausner JM, Even-Sapir E, Figer A, Ben-Haim M. (2007). The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg 11:472–478.
   PubMed Web of Science ®Google Scholar
• McGhana JP, Dodd GD 3rd. (2001). Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 176:3–16.
   PubMed Web of Science ®Google Scholar
• Meta J, Seltzer M, Schiepers C, Silverman DH, Ariannejad M, Gambhir SS, Phelps ME, Valk P, Czernin J. (2001). Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician’s perspective. J Nucl Med 42:586–590.
   PubMed Web of Science ®Google Scholar
• Moses LE, Shapiro D, Littenberg B. (1993). Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12:1293–1316.
   PubMed Web of Science ®Google Scholar
• Owens DK, Holodniy M, Garber AM, Scott J, Sonnad S, Moses L, Kinosian B, Schwartz JS. (1996). Polymerase chain reaction for the diagnosis of HIV infection in adults. A meta-analysis with recommendations for clinical practice and study design. Ann Intern Med 124:803–815.
   PubMed Web of Science ®Google Scholar
• Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. (2005). Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982–990.
   PubMed Web of Science ®Google Scholar
• Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L, Paties CT, Silverman DE, Buscarini L. (1996). Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 167:759–768.
   PubMed Web of Science ®Google Scholar
• Rossi S, Buscarini E, Garbagnati F, Di Stasi M, Quaretti P, Rago M, Zangrandi A, Andreola S, Silverman D, Buscarini L. (1998). Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 170:1015–1022.
   PubMed Web of Science ®Google Scholar
• Ruers TJ, Langenhoff BS, Neeleman N, Jager GJ, Strijk S, Wobbes T, Corstens FH, Oyen WJ. (2002). Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20:388–395.
   PubMed Web of Science ®Google Scholar
• Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. (2011a). Value of PET/CT in the management of liver metastases, part 1. AJR Am J Roentgenol 197:W256–W259.
   PubMed Web of Science ®Google Scholar
• Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. (2011b). Value of PET/CT in the management of primary hepatobiliary tumors, part 2. AJR Am J Roentgenol 197:W260–W265.
   PubMed Web of Science ®Google Scholar
• Sahin DA, Agcaoglu O, Chretien C, Siperstein A, Berber E. (2012). The utility of PET/CT in the management of patients with colorectal liver metastases undergoing laparascopic radiofrequency thermal ablation. Ann Surg Oncol 19:850–855.
   PubMed Web of Science ®Google Scholar
• Schima W, Kulinna C, Langenberger H, Ba-Ssalamah A. (2005). Liver metastases of colorectal cancer: US, CT or MR? Cancer Imaging 5 Spec No A:S149–S156.
   PubMedGoogle Scholar
• Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. (2004). Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240:1027–34; discussion 1035.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. (2001). Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 13:149–158.
   PubMedGoogle Scholar
• Sotiriadis A, Makrydimas G, Ioannidis JP. (2003). Diagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis. Obstet Gynecol 101:1009–1016.
   PubMed Web of Science ®Google Scholar
• Thanos L, Mylona S, Galani P, Pomoni M, Pomoni A, Koskinas I. (2008). Overcoming the heat-sink phenomenon: successful radiofrequency thermal ablation of liver tumors in contact with blood vessels. Diagn Interv Radiol 14:51–56.
   PubMed Web of Science ®Google Scholar
• Travaini LL, Trifirò G, Ravasi L, Monfardini L, Della Vigna P, Bonomo G, Chiappa A, Mallia A, Ferrari M, Orsi F, Paganelli G. (2008). Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results. Eur J Nucl Med Mol Imaging 35:1316–1322.
   PubMed Web of Science ®Google Scholar
• Tsuda M, Rikimaru H, Majima K, Yamada T, Saito H, Ishibashi T, Takahashi S, Miyachi H, Endoh M, Yamada S. (2003). Time-related changes of radiofrequency ablation lesion in the normal rabbit liver: findings of magnetic resonance imaging and histopathology. Invest Radiol 38:525–531.
   PubMed Web of Science ®Google Scholar
• Veit P, Antoch G, Stergar H, Bockisch A, Forsting M, Kuehl H. (2006). Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol 16:80–87.
   PubMed Web of Science ®Google Scholar
• Vogt FM, Antoch G, Veit P, Freudenberg LS, Blechschmid N, Diersch O, Bockisch A, Barkhausen J, Kuehl H. (2007). Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT. J Nucl Med 48:1836–1844.
   PubMed Web of Science ®Google Scholar
• Walter SD. (2002). Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 21:1237–1256.
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM; QUADAS-2 Group. (2011). QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536.
   PubMed Web of Science ®Google Scholar
• Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD 3rd, Dorfman GS, Eng C, Fong Y, Giusti AF, Lu D, Marsland TA, Michelson R, Poston GJ, Schrag D, Seidenfeld J, Benson AB 3rd. (2010). American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28:493–508.
   PubMed Web of Science ®Google Scholar
• Ziakas PD, Poulou LS, Voulgarelis M, Thanos L. (2012). The Gordian knot of interim 18-fluorodeoxyglucose positron emission tomography for Hodgkin lymphoma: a meta-analysis and commentary on published studies. Leuk Lymphoma, May 22 [Epub ahead of print].
   Google Scholar
• Zintzaras E, Germenis AE. (2006). Performance of antibodies against tissue transglutaminase for the diagnosis of celiac disease: meta-analysis. Clin Vaccine Immunol 13:187–192.
   PubMed Web of Science ®Google Scholar